Emergent BioSolutions Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $271.5m $178.3m $112.2m $167.8m $621.3m $576.1m $642.6m $111.7m $99.5m $205.4m
Prepaid Expense and Other Assets, Current $16.2m $17.2m $31.5m $20.4m $36.5m $70.3m $57.9m $47.9m $26.9m $25.8m
Inventory, Net $74.0m $142.8m $205.8m $222.5m $307.0m $350.8m $350.7m $328.9m $311.7m $343.4m
Assets, Current $510.2m $485.4m $620.8m $686.2m $1.2b $1.3b $1.2b $679.5m $598.7m $662.5m
Property, Plant and Equipment, Net $376.4m $407.2m $510.2m $542.3m $644.1m $800.1m $817.6m $382.8m $270.6m $205.4m
Goodwill $41.0m $49.1m $259.7m $266.6m $266.7m $224.9m $218.2m $0 $0 $0
Intangible Assets, Net (Excluding Goodwill) $33.9m $119.6m $761.6m $712.9m $663.1m $604.6m $728.8m $566.6m $501.5m $436.5m
Operating Lease, Right-of-Use Asset $19.4m $16.2m $11.7m $10.6m
Other Assets, Noncurrent $2.5m $6.0m $13.7m $76.9m $113.4m $57.3m $191.3m $194.3m $18.9m $14.2m
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $138.5m $143.7m $262.5m $270.7m $230.9m $274.7m $159.2m $191.0m $154.5m $84.2m
Accrued Liabilities, Current $6.4m $4.8m $30.7m $39.5m $46.9m $51.7m $34.9m $18.6m $17.7m $12.2m
Assets $970.1m $1.1b $2.2b $2.3b $2.9b $3.0b $3.2b $1.8b $1.4b $1.3b
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $5.8m $3.5m $2.7m $2.4m
Accounts Payable, Current $34.6m $41.8m $80.7m $94.8m $136.1m $128.9m $103.5m $112.2m $60.9m $55.6m
Operating Lease, Liability, Noncurrent $14.8m $13.8m $9.7m $9.2m
Deferred Revenue, Current $7.0m $13.2m
Deferred Revenue, Noncurrent $8.4m $17.3m
Long-term Debt, Current Maturities $10.1m $12.9m $33.8m $31.6m $957.3m $413.7m $0
Long-term Debt, Excluding Current Maturities $248.1m $13.5m $784.5m $798.4m $841.0m $809.4m $448.5m $446.5m $663.7m $572.1m
Liabilities, Current $105.9m $100.1m $200.4m $216.3m $384.5m $373.8m $1.2b $651.3m $162.4m $132.2m
Deferred Income Tax Liabilities, Net $63.9m $53.2m $94.9m $59.7m $47.2m $41.7m $37.8m
Other Liabilities, Noncurrent $1.6m $4.7m $38.0m $48.6m $67.8m $52.7m $41.5m $28.9m $39.1m $53.9m
Deferred Tax Liabilities, Net $54.1m $50.5m $43.8m $90.7m $59.7m $47.2m $41.7m $37.8m
Liabilities $373.9m $157.9m $1.2b $1.2b $1.4b $1.3b $1.8b $1.2b $906.9m $796.0m
Stockholders’ equity:
Preferred Stock, Value, Issued $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Common Stock, Value, Issued $41k $50k $100k $100k $100k $100k $100k $100k $100k $100k
Additional Paid in Capital $352.4m $618.4m $688.6m $716.1m $784.9m $829.4m $873.5m $904.4m $928.0m $942.4m
Retained Earnings (Accumulated Deficit) $254.5m $337.1m $367.3m $421.8m $726.9m $957.8m $738.7m ($21.8m) ($212.4m) ($159.8m)
Accumulated Other Comprehensive Income (Loss), Net of Tax ($4.3m) ($3.7m) ($5.5m) ($9.9m) ($25.3m) ($16.1m) $3.1m ($5.7m) ($5.2m) ($7.5m)
Stockholders' Equity Attributable to Parent $1.1b $1.4b $1.6b $1.4b $649.3m $482.8m $522.6m
Liabilities and Equity $970.1m $1.1b $2.2b $2.3b $2.9b $3.0b $3.2b $1.8b $1.4b $1.3b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.